pentobarbital will minimize the extent or influence of roflumilast by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not advised; potent cytochrome P450 enzyme inducers minimize systemic exposure to roflumilast and should decrease the therapeutic performanceThere's a very elementary principle in drugs, prim… Read More